Summit Global Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Summit Global Investments's ELV Position: Q1 2026 in Review
Summit Global Investments reduced its Elevance Health (ELV) stake by 54% in Q1 2026, selling an estimated $1.71M and leaving 4,421 shares worth $1.29M. The position accounts for 0.08% of the portfolio, ranked #139.
Summit Global Investments first reported a position in ELV in Q4 2016 and has held it in 29 quarters since. The position peaked at $19.7M in Q3 2023. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Summit Global Investments held 4,421 shares of Elevance Health worth $1.29M as of Q1 2026.
- Summit Global Investments sold 5,190 Elevance Health shares in Q1 2026, an estimated $1.71M.
- Elevance Health made up 0.08% of Summit Global Investments's portfolio in Q1 2026, its #139 holding.
- Summit Global Investments first reported a position in Elevance Health in Q4 2016 and has held it in 29 quarters since.
- Summit Global Investments's Elevance Health position peaked at $19.7M in Q3 2023.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.